Global Heart Transplantation Therapeutics Market 2024-2028

PUBLISHED: January 11, 2024

PAGES: 172 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The heart transplantation therapeutics market is forecasted to grow by USD 135.37 mn during 2023-2028, accelerating at a CAGR of 3.24% during the forecast period. The report on the heart transplantation therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cardiovascular diseases and heart failures, the availability of drugs in multiple dosage forms, and high dependency on immunosuppressants for heart transplantation.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	2.76%
CAGR	3.24%
Incremental Value	$135.37mn

Technavio's heart transplantation therapeutics market is segmented as below:

By Drug Class

Immunosuppressants
Anti-infectives
Analgesics
Others

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing international collaborations for heart transplantation as one of the prime reasons driving the heart transplantation therapeutics market growth during the next few years. Also, advent of techniques for heart transplantation and growing awareness and accessibility regarding heart transplantation will lead to sizable demand in the market.

The report on the heart transplantation therapeutics market covers the following areas:

Heart transplantation therapeutics market sizing
Heart transplantation therapeutics market forecast
Heart transplantation therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading heart transplantation therapeutics market vendors that include AbbVie Inc., Astellas Pharma Inc., Biocon Ltd., Dr Reddys Laboratories Ltd., Endo International Plc, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., LEO Pharma AS, Lupin Ltd., McKesson Corp., Novartis AG, Pfizer Inc., RPG Enterprises, Strides Pharma Science Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., F. Hoffmann La Roche Ltd., and Panacea Biotec Ltd.. Also, the heart transplantation therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR40272

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global heart transplantation therapeutics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global heart transplantation therapeutics market 2018 - 2022 ($ million)
4.2 Drug Class Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
4.3 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Drug Class

6.1 Market segments
Exhibit 30: Chart on Drug Class - Market share 2023-2028 (%)
Exhibit 31: Data Table on Drug Class - Market share 2023-2028 (%)
6.2 Comparison by Drug Class
Exhibit 32: Chart on Comparison by Drug Class
Exhibit 33: Data Table on Comparison by Drug Class
6.3 Immunosuppressants - Market size and forecast 2023-2028
Exhibit 34: Chart on Immunosuppressants - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Immunosuppressants - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Immunosuppressants - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Immunosuppressants - Year-over-year growth 2023-2028 (%)
6.4 Anti-infectives - Market size and forecast 2023-2028
Exhibit 38: Chart on Anti-infectives - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Anti-infectives - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Anti-infectives - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Anti-infectives - Year-over-year growth 2023-2028 (%)
6.5 Analgesics - Market size and forecast 2023-2028
Exhibit 42: Chart on Analgesics - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Analgesics - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Analgesics - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Analgesics - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Drug Class
Exhibit 50: Market opportunity by Drug Class ($ million)
Exhibit 51: Data Table on Market opportunity by Drug Class ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 52: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 53: Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Exhibit 54: Chart on Comparison by Distribution Channel
Exhibit 55: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacies - Market size and forecast 2023-2028
Exhibit 56: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacies - Market size and forecast 2023-2028
Exhibit 60: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
7.5 Online pharmacies - Market size and forecast 2023-2028
Exhibit 64: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 66: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 68: Market opportunity by Distribution Channel ($ million)
Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Japan - Market size and forecast 2023-2028
Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.11 France - Market size and forecast 2023-2028
Exhibit 107: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibit 108: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibit 109: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on France - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 119: AbbVie Inc. - Overview
Exhibit 120: AbbVie Inc. - Product / Service
Exhibit 121: AbbVie Inc. - Key news
Exhibit 122: AbbVie Inc. - Key offerings
12.4 Astellas Pharma Inc.
Exhibit 123: Astellas Pharma Inc. - Overview
Exhibit 124: Astellas Pharma Inc. - Product / Service
Exhibit 125: Astellas Pharma Inc. - Key news
Exhibit 126: Astellas Pharma Inc. - Key offerings
12.5 Biocon Ltd.
Exhibit 127: Biocon Ltd. - Overview
Exhibit 128: Biocon Ltd. - Business segments
Exhibit 129: Biocon Ltd. - Key offerings
Exhibit 130: Biocon Ltd. - Segment focus
12.6 Dr Reddys Laboratories Ltd.
Exhibit 131: Dr Reddys Laboratories Ltd. - Overview
Exhibit 132: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 133: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 134: Dr Reddys Laboratories Ltd. - Segment focus
12.7 F. Hoffmann La Roche Ltd.
Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
12.8 GlaxoSmithKline Plc
Exhibit 140: GlaxoSmithKline Plc - Overview
Exhibit 141: GlaxoSmithKline Plc - Business segments
Exhibit 142: GlaxoSmithKline Plc - Key news
Exhibit 143: GlaxoSmithKline Plc - Key offerings
Exhibit 144: GlaxoSmithKline Plc - Segment focus
12.9 Glenmark Pharmaceuticals Ltd.
Exhibit 145: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 146: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 147: Glenmark Pharmaceuticals Ltd. - Key offerings
12.10 Intas Pharmaceuticals Ltd.
Exhibit 148: Intas Pharmaceuticals Ltd. - Overview
Exhibit 149: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 150: Intas Pharmaceuticals Ltd. - Key offerings
12.11 LEO Pharma AS
Exhibit 151: LEO Pharma AS - Overview
Exhibit 152: LEO Pharma AS - Business segments
Exhibit 153: LEO Pharma AS - Key offerings
Exhibit 154: LEO Pharma AS - Segment focus
12.12 Lupin Ltd.
Exhibit 155: Lupin Ltd. - Overview
Exhibit 156: Lupin Ltd. - Product / Service
Exhibit 157: Lupin Ltd. - Key news
Exhibit 158: Lupin Ltd. - Key offerings
12.13 Novartis AG
Exhibit 159: Novartis AG - Overview
Exhibit 160: Novartis AG - Business segments
Exhibit 161: Novartis AG - Key offerings
Exhibit 162: Novartis AG - Segment focus
12.14 Panacea Biotec Ltd.
Exhibit 163: Panacea Biotec Ltd. - Overview
Exhibit 164: Panacea Biotec Ltd. - Product / Service
Exhibit 165: Panacea Biotec Ltd. - Key offerings
12.15 Pfizer Inc.
Exhibit 166: Pfizer Inc. - Overview
Exhibit 167: Pfizer Inc. - Product / Service
Exhibit 168: Pfizer Inc. - Key news
Exhibit 169: Pfizer Inc. - Key offerings
12.16 Sun Pharmaceutical Industries Ltd.
Exhibit 170: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 171: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 172: Sun Pharmaceutical Industries Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 173: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 174: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 176: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 177: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 178: Inclusions checklist
Exhibit 179: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 180: Currency conversion rates for US$
13.4 Research methodology
Exhibit 181: Research methodology
Exhibit 182: Validation techniques employed for market sizing
Exhibit 183: Information sources
13.5 List of abbreviations
Exhibit 184: List of abbreviations

Product Code: IRTNTR40272

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global heart transplantation therapeutics market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Drug Class - Market share 2023-2028 (%)
Exhibits31: Data Table on Drug Class - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Drug Class
Exhibits33: Data Table on Comparison by Drug Class
Exhibits34: Chart on Immunosuppressants - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Immunosuppressants - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Immunosuppressants - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Immunosuppressants - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Anti-infectives - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Anti-infectives - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Anti-infectives - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Anti-infectives - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Analgesics - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Analgesics - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Analgesics - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Analgesics - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Drug Class ($ million)
Exhibits51: Data Table on Market opportunity by Drug Class ($ million)
Exhibits52: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits53: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits54: Chart on Comparison by Distribution Channel
Exhibits55: Data Table on Comparison by Distribution Channel
Exhibits56: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits65: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits66: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by Distribution Channel ($ million)
Exhibits69: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits108: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits109: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: AbbVie Inc. - Overview
Exhibits120: AbbVie Inc. - Product / Service
Exhibits121: AbbVie Inc. - Key news
Exhibits122: AbbVie Inc. - Key offerings
Exhibits123: Astellas Pharma Inc. - Overview
Exhibits124: Astellas Pharma Inc. - Product / Service
Exhibits125: Astellas Pharma Inc. - Key news
Exhibits126: Astellas Pharma Inc. - Key offerings
Exhibits127: Biocon Ltd. - Overview
Exhibits128: Biocon Ltd. - Business segments
Exhibits129: Biocon Ltd. - Key offerings
Exhibits130: Biocon Ltd. - Segment focus
Exhibits131: Dr Reddys Laboratories Ltd. - Overview
Exhibits132: Dr Reddys Laboratories Ltd. - Business segments
Exhibits133: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits134: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits135: F. Hoffmann La Roche Ltd. - Overview
Exhibits136: F. Hoffmann La Roche Ltd. - Business segments
Exhibits137: F. Hoffmann La Roche Ltd. - Key news
Exhibits138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits139: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits140: GlaxoSmithKline Plc - Overview
Exhibits141: GlaxoSmithKline Plc - Business segments
Exhibits142: GlaxoSmithKline Plc - Key news
Exhibits143: GlaxoSmithKline Plc - Key offerings
Exhibits144: GlaxoSmithKline Plc - Segment focus
Exhibits145: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits146: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits147: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits148: Intas Pharmaceuticals Ltd. - Overview
Exhibits149: Intas Pharmaceuticals Ltd. - Product / Service
Exhibits150: Intas Pharmaceuticals Ltd. - Key offerings
Exhibits151: LEO Pharma AS - Overview
Exhibits152: LEO Pharma AS - Business segments
Exhibits153: LEO Pharma AS - Key offerings
Exhibits154: LEO Pharma AS - Segment focus
Exhibits155: Lupin Ltd. - Overview
Exhibits156: Lupin Ltd. - Product / Service
Exhibits157: Lupin Ltd. - Key news
Exhibits158: Lupin Ltd. - Key offerings
Exhibits159: Novartis AG - Overview
Exhibits160: Novartis AG - Business segments
Exhibits161: Novartis AG - Key offerings
Exhibits162: Novartis AG - Segment focus
Exhibits163: Panacea Biotec Ltd. - Overview
Exhibits164: Panacea Biotec Ltd. - Product / Service
Exhibits165: Panacea Biotec Ltd. - Key offerings
Exhibits166: Pfizer Inc. - Overview
Exhibits167: Pfizer Inc. - Product / Service
Exhibits168: Pfizer Inc. - Key news
Exhibits169: Pfizer Inc. - Key offerings
Exhibits170: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits171: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits172: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits173: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits174: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits175: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits176: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits177: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations